SERUM SIALIC-ACID AND ACUTE-PHASE PROTEINS IN HYPERTRIGLYCERIDEMIC PATIENTS SHOWING THE FREDERICKSON TYPE-IIB PHENOTYPE

被引:8
作者
HAQ, S [1 ]
TUTT, P [1 ]
HAQ, M [1 ]
CROOK, M [1 ]
机构
[1] GUYS HOSP,DEPT CLIN CHEM,5TH FLOOR TOWER,LONDON SE1 9RT,ENGLAND
基金
英国惠康基金;
关键词
ACUTE-PHASE PROTEINS; CARDIOVASCULAR RISK; HYPERTRIGLYCERIDEMIA; SIALIC ACID;
D O I
10.1042/cs0850219
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
1. We have shown that serum total sialic acid is elevated in hypertriglyceridaemic patients showing the Frederickson's type IIB phenotype in comparison with normal subjects (2.30+/-0.34 versus 1.92+/-0.32 mmol/l, P<0.02). Lipid-associated sialic acid was also elevated in the hypertriglyceridaemic group in comparison with the normal subjects (0.60+/-0.09 versus 0.35+/-0.04 mmol/l, P<0.001). 2. We measured five serum acute-phase proteins in the hypertriglyceridaemic patients and the normal subjects, namely alpha1-antichymotrypsin, alpha1-acid glycoprotein, alpha2-macroglobulin, C-reactive protein and haptoglobin. SeruM alpha2-macroglobulin was significantly elevated in the hypertriglyceridaemic patients compared with the normal subjects (2.1+/-1.0 versus 1.5+/-0.55 g/l, P<0.05) as was serum C-reactive protein (5.9+/-3.5 versus 3.5+/-1.9 mg/l, P<0.05). There were, however, no significant differences in the serum concentrations of alpha1-antichymotrypsin, alpha1-acid glycoprotein or haptoglobin between the two groups. 3. There was a significant correlation between serum total sialic acid and serum alpha1-antichymotrypsin, alpha1-acid glycoprotein and haptoglobin (Spearman correlation coefficients 0.74, 0.50 and 0.76, respectively) in the normal subjects, and there was a significant correlation between serum total sialic acid and serum alpha1-antichymotrypsin and alpha1-acid glycoprotein (Spearman correlation coefficients 0.72 and 0.84, respectively) in the hypertriglyceridaemic patients.
引用
收藏
页码:219 / 222
页数:4
相关论文
共 19 条
[1]   SERUM SIALIC-ACID CONCENTRATION IN PATIENTS WITH HYPERTRIGLYCERIDEMIA SHOWING THE FREDERICKSON IIB PHENOTYPE [J].
CROOK, M ;
TUTT, P .
CLINICAL SCIENCE, 1992, 83 (05) :593-595
[2]   ELEVATED SERUM SIALIC-ACID CONCENTRATION IN NIDDM AND ITS RELATIONSHIP TO BLOOD-PRESSURE AND RETINOPATHY [J].
CROOK, MA ;
TUTT, P ;
PICKUP, JC .
DIABETES CARE, 1993, 16 (01) :57-60
[3]   TOTAL AND LIPID-BOUND SIALIC-ACID LEVELS IN SERA FROM PATIENTS WITH CANCER [J].
HORGAN, IE .
CLINICA CHIMICA ACTA, 1982, 118 (2-3) :327-331
[4]  
Hrncir Z, 1975, Vnitr Lek, V21, P436
[5]  
KAPTODIS N, 1980, RES COMMUN CHEM PATH, V30, P171
[6]   SERUM SIALIC-ACID CONCENTRATION AND SMOKING - A POPULATION BASED STUDY [J].
LINDBERG, G ;
RASTAM, L ;
GULLBERG, B ;
EKLUND, GA ;
TORNBERG, S .
BRITISH MEDICAL JOURNAL, 1991, 303 (6813) :1306-1307
[7]   SERUM SIALIC-ACID CONCENTRATION AND CARDIOVASCULAR MORTALITY [J].
LINDBERG, G ;
EKLUND, GA ;
GULLBERG, B ;
RASTAM, L .
BRITISH MEDICAL JOURNAL, 1991, 302 (6769) :143-146
[8]   SERUM SIALIC-ACID CONCENTRATION PREDICTS BOTH CORONARY HEART-DISEASE AND STROKE MORTALITY - MULTIVARIATE-ANALYSIS INCLUDING 54385 MEN AND WOMEN DURING 20.5 YEARS FOLLOW-UP [J].
LINDBERG, G ;
RASTAM, L ;
GULLBERG, B ;
EKLUND, GA .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1992, 21 (02) :253-257
[9]   SIALIC-ACID IN HUMAN CANCER [J].
MABRY, EW ;
CARUBELLI, R .
EXPERIENTIA, 1972, 28 (02) :182-+
[10]   DESIALYLATED LOW-DENSITY-LIPOPROTEIN - NATURALLY-OCCURRING MODIFIED LIPOPROTEIN WITH ATHEROGENIC POTENCY [J].
OREKHOV, AN ;
TERTOV, VV ;
MUKHIN, DN .
ATHEROSCLEROSIS, 1991, 86 (2-3) :153-161